Immunoadsorption Versus Plasma Exchange for Treatment of Guillain-Barré Syndrome (GBS)

RecruitingOBSERVATIONAL
Enrollment

20

Participants

Timeline

Start Date

April 28, 2021

Primary Completion Date

May 4, 2025

Study Completion Date

May 4, 2025

Conditions
GBS
Interventions
DEVICE

Immunoadsorption

1 cycle, consisting of 5 sessions on 5 consecutive days with processing of the 0.7-fold individual plasma volume (maximum 2.5 l) each days with tryptophan adsorbers.

DEVICE

Plasma Exchange

1 cycle, consisting of 5 sessions on 5 consecutive days with exchange of 0.7-fold plasma volume (maximum 2.5 l) each day with albumin solution as volume replacement solution.

Trial Locations (1)

89081

RECRUITING

Department of Neurology, University of Ulm, Ulm

All Listed Sponsors
collaborator

DiaMed GmbH

INDUSTRY

lead

University of Ulm

OTHER